Nature Publishing Group (NPG) and the European Molecular Biology Organization (EMBO) have announced that the prices for site licence access to The EMBO Journal and EMBO reports will be reduced by 9% in 2010, reflecting the increased publication of Open Access content in 2008.
A Fri, study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: